Viral hepatitis is an inflammation of the liver caused by hepatitis viruses A, B, C, D and every year 1.4 million die due to hepatitis, globally.
Dr Khullar said there are about 400 million people living with hepatitis B and C in the world and 1.4 million die due to these infections every year. "Viral hepatitis is an inflammation of the liver caused by hepatitis viruses A, B, C, D and E. Hepatitis A and E are transmitted through contaminated food and water. Hepatitis B is transmitted through unsafe blood and body fluids, and Hepatitis-C mostly through unsafe blood," he said.
"All these viruses cause acute hepatitis- causing symptoms of fatigue, loss of appetite, fever, yellowness of eyes and urine etc. Most of the people fully recover. A small number can die from acute hepatitis," he added.
Dr Khullar further said that Hepatitis B and C can become chronic and lead to liver cirrhosis and liver cancer. "Hepatitis infections can be prevented by providing safe drinking water and food (hepatitis A and E) and vaccines (hepatitis A and B) screening of blood and sterile injection techniques. Hepatitis B and C can be sexually transmitted and to the newborn child through mother," he further added.
Doctors to Study High Prevalence of Hepatitis B and C in Himachal Pradesh
High Prevalence of Hepatitis B and C viruses in the Indian state may be due to unscreened blood transfusions, and the use of unsterilized needles and syringes.
High Prevalence of Hepatitis B and C viruses in the Indian state may be due to unscreened blood transfusions, and the use of unsterilized needles and syringes.
Coordinated Action Needed to Detect, Control, Treat Hepatitis: World Health Organization
India alone has 40 million people living with chronic hepatitis B infection. Sixty percent of the people living with HIV are co-infected with hepatitis.
India alone has 40 million people living with chronic hepatitis B infection. Sixty percent of the people living with HIV are co-infected with hepatitis.
Hepatitis C Pandemic Could be Curbed Via Paper-Based Diagnostics
The U.S. Food and Drug Administration approved two new treatments late last year much to the relief of patients diagnosed with hepatitis C.
The U.S. Food and Drug Administration approved two new treatments late last year much to the relief of patients diagnosed with hepatitis C.
New Combination of Pills Cure Hepatitis C Patients: Study
A combination of pills that cures 9 of 10 hepatitis C patients and is well tolerated by patients, reveals a new study.
A combination of pills that cures 9 of 10 hepatitis C patients and is well tolerated by patients, reveals a new study.
